Holy Cross — Fort Lauderdale, Florida

Holy Cross is a clinical research site located in Fort Lauderdale, Florida, United States 33308.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Holy Cross has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Non-small Cell Lung Cancer Metastatic, Non-small Cell Lung Cancer, Solid Tumor.

Sponsors: Guardant Health, Inc., EMD Serono Research & Development Institute, Inc., Tempus AI.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Holy Cross?

Holy Cross has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Holy Cross conducted?

Holy Cross has 3 clinical trials on record, with 1 currently active. Their work covers Non-small Cell Lung Cancer Metastatic, Non-small Cell Lung Cancer, Solid Tumor.

Is Holy Cross accredited by Crixeo Health?

Holy Cross has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Holy Cross?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.